LifeMD: The Dip Could Deepen, Valuation More Attractive

While LifeMD (NASDAQ: LFMD ) continues to record strong growth from its telehealth platforms, dual misses for its fiscal 2025 second quarter have led investors to revise previous estimates for growth downwards. I'm more neutral on the commons The equity market is a powerful mechanism as daily fluctuations in price get aggregated to incredible wealth creation or destruction over the long term. Pacifica Yield aims to pursue long-term wealth creation with a focus on undervalued yet high-growth companies, high- ...